NCT00906256View on ClinicalTrials.gov

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD7295

Capsules 260mg, 455mg, 650mg (single doses), 650mg q12h, 650mg q8h.

DRUG

Placebo

Placebo

Trial Locations (1)

NG11 6JS

Pharmaceutical Profiles Ltd, Nottingham

Sponsors

Lead Sponsor

Arrow Therapeutics

All Listed Sponsors

lead

Arrow Therapeutics

INDUSTRY

NCT00906256 - Clinical Pharmacology Study of AZD7295 in Healthy Subjects | Biotech Hunter | Biotech Hunter